10-Q: Nanophase Technologies Reports Strong Revenue Growth in Second Quarter 2024, Fueled by Solsence Products

Nanophase Technologies saw a significant increase in revenue during the second quarter of 2024, driven primarily by the growth of its Solsence beauty science subsidiary.

Summary

• Nanophase Technologies Corporation reported a revenue increase to $13.05 million for the three months ended June 30, 2024, compared to $11.87 million for the same period in 2023.
• For the six months ended June 30, 2024, total revenue reached $22.91 million, up from $21.33 million in the same period of 2023.
• The company's product revenue increased to $12.92 million for the three months ended June 30, 2024, and $22.69 million for the six months ended June 30, 2024.
• The increase in revenue was primarily driven by the growth of Solsence products, which offset a decrease in API sales in the personal care ingredients business.
• Net income for the three months ended June 30, 2024, was $856,000, or $0.02 per basic share, compared to $333,000, or $0.01 per basic share, for the same period in 2023.
• Net income for the six months ended June 30, 2024, was $1.75 million, or $0.03 per basic share, compared to a net loss of $825,000, or -$0.02 per basic share, for the same period in 2023.
• The company's gross profit for the three months ended June 30, 2024, was $3.74 million, and $7.32 million for the six months ended June 30, 2024.
• The company issued 15,000 shares of Series X Preferred Stock for $6 million, which were later converted into 15 million shares of common stock.

Sentiment

Score: 8

Explanation: The document shows strong revenue growth and a return to profitability, indicating a positive outlook. The resolution of the BASF legal issue and the successful capital raise further contribute to the positive sentiment. However, some risks remain, such as dependence on key customers and potential refinancing challenges.

Positives

• The company experienced significant revenue growth, driven by the success of its Solsence products.
• The company achieved profitability for both the three and six months ended June 30, 2024, a significant improvement compared to the same periods in 2023.
• The company successfully raised $6 million through the issuance of Series X Preferred Stock, which was later converted to common stock.
• The company's cash position improved, indicating a stronger financial footing.
• The company resolved a legal dispute with BASF, which included an amendment to their supply agreement.

Negatives

• The company experienced a decrease in API sales to its largest customer in the personal care ingredients business.
• The cost of revenue increased due to higher demand and manufacturing inefficiencies.
• The company's loan agreements with Strandler, LLC and Beachcorp. LLC are set to expire on October 1, 2025, which could pose a refinancing risk.
• The company's inventory reserve increased to $1.595 million as of June 30, 2024, compared to $677,000 as of December 31, 2023.

Risks

• The company is dependent on a limited number of key customers, and the loss of any of these customers could significantly impact revenue.
• The company's supply agreement with BASF could trigger a requirement to sell equipment to that customer.
• The company may face challenges in obtaining working capital when needed.
• The company's ability to pass through material cost increases to customers is not guaranteed.
• The company faces risks related to market acceptance of its Solsence products and advanced materials.
• The company's manufacturing capacity and product mix flexibility could be challenged by customer demand.
• The company has limited marketing experience, particularly with its Solsence products.
• The company is dependent on patents and protection of proprietary information.
• The company could be impacted by new governmental regulations, especially those related to nanomaterials.
• The company could experience business interruptions due to unexpected events or public health crises.
• The company's loan agreements with Strandler, LLC and Beachcorp. LLC are set to expire on October 1, 2025, which could become an operating risk if they are not able to refinance or extend the maturity dates.

Future Outlook

The company expects that as product revenue volume increases, its fixed manufacturing costs will be more efficiently absorbed, which should lead to increased margins. The company also expects capital spending relating to currently known capital needs for 2024 will be between $3 million and $6 million, to be funded by profit from operations, existing loans and lines of credit, and possible new debt financing.

Management Comments

• Management believes that the growth in beauty science is happening now due to a confluence of our technology, market conditions that favor what we produce, and our expanded expertise in these areas.
• Management plans on expanding efforts in areas where they have proven they can deliver innovation and growth.

Industry Context

The company is operating in the growing beauty and life science markets, with a focus on skin health. The company's Solsence products are positioned to meet the increasing consumer demand for clean and inclusive beauty. The company's vertical integration helps to improve efficiency and avoid potential major supply chain challenges while also addressing ongoing sustainability efforts.

Comparison to Industry Standards

• The company's revenue growth is strong compared to some smaller companies in the specialty materials and personal care ingredients space, but it is difficult to make a direct comparison without knowing the specific growth rates of comparable companies.
• The company's shift towards finished products through Solsence is a strategy that is being adopted by other ingredient suppliers in the personal care industry, such as Croda and Ashland, who are also moving towards offering more finished formulations.
• The company's focus on mineral-based solutions aligns with the trend towards natural and clean beauty, which is a growing segment of the market.
• The company's vertical integration is a competitive advantage, similar to companies like L'Oreal and Estee Lauder, who have control over their supply chains.

Legal Proceedings

• The company resolved a legal dispute with BASF, which included an amendment to their supply agreement.

Related Party Transactions

• The company has loan agreements with Beachcorp, LLC and Strandler, LLC, which are affiliates of a major shareholder and a director of the company.

Stakeholder Impact

• Shareholders will benefit from the company's improved financial performance and growth prospects.
• Employees may benefit from the company's growth and expansion.
• Customers will benefit from the company's innovative products and solutions.
• Suppliers may benefit from the company's increased demand for materials.
• Creditors may benefit from the company's improved financial stability.

Next Steps

• The company will continue to focus on reducing controllable variable product manufacturing costs.
• The company will continue to focus on expanding its manufacturing capabilities.
• The company will continue to focus on developing new product formulations and related technologies.
• The company will continue to focus on expanding marketing and sales efforts relating to its Solsence products.

Key Dates

Keywords

Nanophase Technologies, Solsence, skin health, personal care ingredients, advanced materials, zinc oxide, revenue growth, financial results, preferred stock, manufacturing, cosmetics, dermatology